AbbVie
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
This week's dividend activity included increased payouts from PB Financial (OTCQX:PBNC) and Ryder (R) as well as declarations from companies such as CVS Health...
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see AbbVie Inc. ( ) is about to trade ex-dividend in the n...
IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation Inc., and AbbVie Inc. ABBV, on Thursday, announced an exclusive lice...
Analyst ratings
60%
of 30 ratingsMore ABBV News
Abbvie ((ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks P...
AbbVie (NYSE:ABBV) and IGI Therapeutics SA, a unit of Ichnos Glenmark Innovation, entered into a licensing agreement for IGI's lead research drug, ISB 2001, aim...
Analyst Chris Schott of J.P. Morgan maintained a Buy rating on AbbVie, with a price target of $200.00. Don’t Miss TipRanks’ Half-Year Sale Take advantage of T...
Pfizer Inc ((PFE)), Abbvie ((ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take adv...